Sunday February 17, 2019

Reforming healthcare system: AAP government to set up patient welfare committees in Delhi hospitals

0
//

stestoskop-64276_640

By Newsgram Staff Writer

To deal with the public grievances on various health and medical issues, Arvind Kejriwal led Aam Aadmi Party today announced plans to set up patient welfare committees at all government hospitals in Delhi.

Under this plan,  there will be 38 such committees in the government hospitals which will be headed by the local MLAs of the area. The representatives of the public will get an office space in the hospital premises to address the concerns of the patients.

Elaborating on how these welfare groups will benefit the people, the state Health Minister Satyendra Jain said,” The role of the committees will be to deal with day to day public grievances and resolve these issues at local level. Decisions on issues like lack of medicines, cleanliness and treatment will be taken on the spot by these committees.”

The patient welfare committees will ensure community participation and monitor functioning of health care facilities, the minister said.

The Health Minister also announced the plans of setting up 10 district committees to monitor the condition of dispensaries and other health programmes in the national capital.

“These district committees will ensure that the dispensaries across the city have all the essential medicines and cater to the medical needs of the public,” Jain said, and added that these groups will also look after the health programmes launched for public welfare in the city.

Talking about the state government’s immunization programme, Jain said that Delhi government has given de-worming medicines to 35 lakh students (1 to 19-years of age) under the immunization programme called Indradhanush Kawach.

“This immunization programme is being held in all parts of the city and the idea is to strengthen it in the coming months. This month we held it at 700-800 centers but we plan to take this number to 1,000. Our target is that 100 per cent kids of the city are immunized,” Jain said.

Next Story

Cases of Swine Flu Crosses 1,000-Mark in Delhi

The advisory also said that children with mild illness but with predisposing risk factors, pregnant women, persons aged 65 years or older, patients with lung diseases, heart disease, liver disease, kidney disease etc.

0
Swine Flu

As many as 1,011 cases of swine flu (H1N1) were reported from various hospitals in the national capital till Sunday, according to a data released by the government on Monday.

Although the government data does not report any deaths due to H1N1, some city hospitals claim that 11 persons died last month due to the infection.

In entire 2018, only 205 H1N1 cases and two deaths were reported.

Till January 29, the number of cases were 512.

The Delhi government has directed all its hospitals to make local purchases of logistics required to ensure a continuous supply of medicine, vaccine and kits.

Representational image.

“All government hospitals are equipped with the necessary logistics required for the management of Seasonal Influenza A (H1N1),” the government said in a statement.

A health advisory has also been issued in both Hindi and English by the Delhi’s Directorate General of Health Services, it said.

According to the advisory, Seasonal Influenza (H1N1) is a self-limiting air-borne viral, and the disease spreads from person to person through coughing and sneezing, indirect contact by touching a contaminated object or surface, and close contact including handshakes, hugging and kissing.

Also Read- Facebook Says That it Has Changed Over Years

“The symptoms include fever and cough, sore throat, runny or stuffy nose and difficulty in breathing. Other symptoms may include body-ache, headache, fatigue, chills, diarrhea and vomiting, and blood-stained sputum,” it said.

The advisory also said that children with mild illness but with predisposing risk factors, pregnant women, persons aged 65 years or older, patients with lung diseases, heart disease, liver disease, kidney disease, blood disorders, diabetes, neurological disorders, cancer and HIV/AIDS, patients on long-term cortisone therapy are under the high-risk group. (IANS)